Durvalumab
- All
- News
-
What Is Imfinzi Durvalumab, The Cancer Drug That Just Got Approval For Use In India?
Unlike traditional chemotherapy, which attacks rapidly dividing cells (both healthy and cancerous), Durvalumab helps your own immune system recognise and destroy cancer cells. It targets a specific protein called PD-L1.
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
Budget 2024: Centre To Remove Customs Duty On 3 Life-Saving Cancer Medicines
Union Finance Minister Nirmala Sitharaman proposed to completely slash the custom duties on three cancer medicines. Centre has proposed to cut the custom duties on Trastuzumab Deruxtecan, Osimertinib and Durvalumab from 10 per cent to zero.
-
What Is Imfinzi Durvalumab, The Cancer Drug That Just Got Approval For Use In India?
Unlike traditional chemotherapy, which attacks rapidly dividing cells (both healthy and cancerous), Durvalumab helps your own immune system recognise and destroy cancer cells. It targets a specific protein called PD-L1.
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
Budget 2024: Centre To Remove Customs Duty On 3 Life-Saving Cancer Medicines
Union Finance Minister Nirmala Sitharaman proposed to completely slash the custom duties on three cancer medicines. Centre has proposed to cut the custom duties on Trastuzumab Deruxtecan, Osimertinib and Durvalumab from 10 per cent to zero.
